cephalosporin c has been researched along with fropenem in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 9 (56.25) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
Abe, T; Domon, H; Fukuoka, T; Ishii, C; Kakuta, M; Kawada, H; Kitayama, A; Ohya, S; Utsui, Y | 1 |
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
Hanaki, H; Hiramatsu, K; Inaba, Y | 1 |
Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Nishiyama, T; Saika, T | 1 |
Nishino, T; Oh, T; Okuda, J; Otsuki, M | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
Sakata, H | 1 |
Ichimaru, T | 1 |
Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F | 1 |
Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E | 1 |
Carlson, EE; Kocaoglu, O; Tsui, HC; Winkler, ME | 1 |
Fukushima, Y; Hiyama, Y; Masumori, N; Nakajima, C; Sato, T; Shinagawa, M; Suzuki, Y; Takahashi, S; Yokota, SI | 1 |
16 other study(ies) available for cephalosporin c and fropenem
Article | Year |
---|---|
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Lactams; Male; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Prodrugs; Streptococcus pneumoniae | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
[Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cephalosporins; Drug Resistance, Microbial; Lactams; Penicillin G; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
[In vitro activity of faropenem against beta-lactamase producing clinical isolates].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Humans; Lactams; Microbial Sensitivity Tests | 2000 |
In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Lactams; Microbial Sensitivity Tests | 2000 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Study on Streptococcus pneumoniae isolated from infants in widely-separated primary care facilities in Japan].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child Day Care Centers; Child, Preschool; Drug Resistance, Bacterial; Humans; Infant; Japan; Lactams; Otitis Media; Penicillin G; Serotyping; Siblings; Streptococcus pneumoniae | 2001 |
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins | 2008 |
Antimicrobial development in the era of emerging resistance.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration | 2009 |
Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Doripenem; Electrophoresis, Polyacrylamide Gel; Meropenem; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins | 2015 |
Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles.
Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carbapenems; Cephalosporin Resistance; Cephalosporins; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae | 2019 |